ORIGINAL ARTICLE
Universal pharmacological thromboprophylaxis for total knee arthroplasty may not be necessary in low-risk populations: a nationwide study in Taiwan
Article first published online: 4 JAN 2012
DOI: 10.1111/j.1538-7836.2011.04555.x
© 2011 International Society on Thrombosis and Haemostasis
Additional Information
How to Cite
LEE, C.-H., CHENG, C.-L., CHANG, C.-H., KAO YANG, Y.-H., LIN, L.-J., LIN, T.-C. and YANG, C.-Y. (2012), Universal pharmacological thromboprophylaxis for total knee arthroplasty may not be necessary in low-risk populations: a nationwide study in Taiwan. Journal of Thrombosis and Haemostasis, 10: 56–63. doi: 10.1111/j.1538-7836.2011.04555.x
Publication History
- Issue published online: 4 JAN 2012
- Article first published online: 4 JAN 2012
- Accepted manuscript online: 8 NOV 2011 10:03AM EST
- Received 3 May 2011, accepted 3 November 2011
Keywords:
- deep vein thrombosis;
- epidemiology;
- knee replacement surgery;
- pulmonary embolism;
- thromboprophylaxis;
- venous thromboembolism
Summary. Background: Thromboprophylaxis should be universally administered in major orthopedic surgery. However, epidemiology of venous thromboembolism (VTE) following major knee surgery in Asia is scarce. Objective: To describe the use of thromboprophylaxis and calculate the incidence and risk factors of symptomatic VTE following major knee surgery in Taiwan. Methods: We used Taiwan’s National Health Insurance Research Database to retrospectively identify patients (≧45 years) who underwent major knee surgery from 1998 to 2007 and collected the medical records within 3 months after the discharge. Logistic regression analysis was used to determine the risk factors of symptomatic VTE after the surgery. Results: We identified 113 844 patients (mean age, 69.0 ± 7.7 years; female, 75.2%) receiving major knee arthroplasties. The mean length of stay was 9.1 ± 3.3 days. The overall pharmacological thromboprophylaxis rate was 2.2%. The 3-month cumulative incidence of procedure-related symptomatic VTE was 0.46% (95% CI, 0.42–0.50%). The median time to the first post-operation VTE was 7 days, with 85.4% occurring within 2 weeks after the discharge. Logistic regression analysis showed that previous VTE, malignancy, heart failure and neurologic disorder with extremity paralysis or pararesis were independent risk factors (P < 0.05) for symptomatic VTE following major knee arthroplasties. Conclusions: The thromboprophylaxis rate is low, which may be due to the very low incidence of symptomatic VTE after the surgery in Taiwan. Most symptomatic VTE occurred within 2 weeks after the surgery. Universal thromboprophylaxis for knee arthroplasties may not be necessary in Taiwan, but it should be considered in some high-risk populations.

1538-7836/asset/olbannerleft.gif?v=1&s=77e14c4c55f90ae6eb6fec99ac201108f7c92510)
1538-7836/asset/olbannerright.gif?v=1&s=87cd273ca1fd9dc5d95b1da3d90fa3ee7637f329)
